Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs).
Infectious Disease Division, Winthrop-University Hospital, 222 Station Plaza North (Suite #432), Mineola, NY, 11501, USA, bacunha@winthrop.org.
B A
BA
Cunha
D000900:Anti-Bacterial Agents / Q000191:economics*; D005260:Female; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000191:economics*; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000191:economics*
D000900:Anti-Bacterial Agents